TY - JOUR
T1 - Topical psoriasis therapy
AU - Federman, Daniel G.
AU - Froelich, Catherine W.
AU - Kirsner, Robert S.
PY - 1999/2/15
Y1 - 1999/2/15
N2 - Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population. Until recently, the mainstays of topical therapy have been corticosteroids, tars, anthralins and keratolytics. Recently, however, vitamin D analogs, a new anthralin preparation and topical retinoids have expanded physicians' therapeutic armamentarium. These new topical therapies offer increased hope and convenience to the large patient population with psoriasis.
AB - Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population. Until recently, the mainstays of topical therapy have been corticosteroids, tars, anthralins and keratolytics. Recently, however, vitamin D analogs, a new anthralin preparation and topical retinoids have expanded physicians' therapeutic armamentarium. These new topical therapies offer increased hope and convenience to the large patient population with psoriasis.
UR - http://www.scopus.com/inward/record.url?scp=0033558254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033558254&partnerID=8YFLogxK
M3 - Article
C2 - 10068717
AN - SCOPUS:0033558254
VL - 59
SP - 957
EP - 962
JO - American Family Physician
JF - American Family Physician
SN - 0002-838X
IS - 4
ER -